These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 1467169)

  • 1. Reevaluation of iron absorption and serum ferritin in beta-thalassemia intermedia.
    Gümrük F; Gürgey A; Duru F; Altay C
    Pediatr Hematol Oncol; 1992; 9(4):359-63. PubMed ID: 1467169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary nonheme iron is equally bioavailable from ferritin or ferrous sulfate in thalassemia intermedia.
    Khurana M; Fung EB; Vichinsky EP; Theil EC
    Pediatr Hematol Oncol; 2017 Nov; 34(8):455-467. PubMed ID: 29232169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver iron concentrations and urinary hepcidin in beta-thalassemia.
    Origa R; Galanello R; Ganz T; Giagu N; Maccioni L; Faa G; Nemeth E
    Haematologica; 2007 May; 92(5):583-8. PubMed ID: 17488680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T2* MRI in regularly transfused children with thalassemia intermedia: serum ferritin does not reflect liver iron stores.
    Tony S; Daar S; Elshinawy M; Al-Zadjaly S; Al-Khabori M; Wali Y
    Pediatr Hematol Oncol; 2012 Sep; 29(6):579-84. PubMed ID: 22839111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepcidin levels and iron status in beta-thalassemia major patients with hepatitis C virus infection.
    Hendy OM; Allam M; Allam A; Attia MH; El Taher S; Eldin MM; Ali A
    Egypt J Immunol; 2010; 17(2):33-44. PubMed ID: 23082485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated liver iron concentration is a marker of increased morbidity in patients with β thalassemia intermedia.
    Musallam KM; Cappellini MD; Wood JC; Motta I; Graziadei G; Tamim H; Taher AT
    Haematologica; 2011 Nov; 96(11):1605-12. PubMed ID: 21791471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum angiogenin level in sickle cell disease and beta thalassemia patients.
    Matter RM; Abdelmaksoud AA; Shams MA; Bebawy EK
    Pediatr Hematol Oncol; 2014 Feb; 31(1):50-6. PubMed ID: 24483841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of Deferasirox (Exjade®) in Modulation of Iron Overload in Patients with β-Thalassemia Intermedia.
    Karimi M; Arandi N; Haghpanah S; Ansari S; Azarkeyvan A; Bordbar M; Safaei S
    Hemoglobin; 2015; 39(5):327-9. PubMed ID: 26114738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum ferritin in beta-thalassemia trait.
    Loria A; Konijn AM; Hershko C
    Isr J Med Sci; 1978 Nov; 14(11):1127-31. PubMed ID: 750537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pantoprazole reduces serum ferritin in patients with thalassemia major and intermedia: A randomized, controlled study.
    Eghbali A; Khalilpour A; Taherahmadi H; Bagheri B
    Therapie; 2019 Oct; 74(5):507-512. PubMed ID: 30704764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum Hepcidin as a Diagnostic Marker of Severe Iron Overload in Beta-thalassemia Major.
    Kaddah AM; Abdel-Salam A; Farhan MS; Ragab R
    Indian J Pediatr; 2017 Oct; 84(10):745-750. PubMed ID: 28600663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of splenectomy on iron balance in patients with β-thalassemia major: a long-term follow-up.
    Casale M; Cinque P; Ricchi P; Costantini S; Spasiano A; Prossomariti L; Minelli S; Frega V; Filosa A
    Eur J Haematol; 2013 Jul; 91(1):69-73. PubMed ID: 23581970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of heart and liver iron deposition status in patients with β- thalassemia intermedia and major with MRI T2* technique].
    Li CG; Liu SX; Mai HR; Wang Y; Wen FQ; Liu RY; Zhang XH; Chu WC; Au WY
    Zhongguo Dang Dai Er Ke Za Zhi; 2012 Feb; 14(2):110-3. PubMed ID: 22357467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary Functions in Children With Thalassemia Major.
    Ozyoruk D; Misirlioglu ED
    J Pediatr Hematol Oncol; 2015 Nov; 37(8):605-10. PubMed ID: 26422288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of serum ferritin levels with hepatic MRI T2 and liver iron concentration in nontransfusion beta-thalassemia intermediate patients: A contemporary issue.
    Karimi M; Amirmoezi F; Haghpanah S; Ostad S; Lotfi M; Sefidbakht S; Rezaian S
    Pediatr Hematol Oncol; 2017 Aug; 34(5):292-297. PubMed ID: 29190176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iron metabolism in thalassemia intermedia.
    Fiorelli G; Fargion S; Piperno A; Battafarano N; Cappellini MD
    Haematologica; 1990; 75 Suppl 5():89-95. PubMed ID: 2086386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum ferritin concentrations in transfusion dependent beta-thalassaemia.
    George E; Wong HB; George R; Ariffin WA
    Singapore Med J; 1994 Feb; 35(1):62-4. PubMed ID: 8009283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iron status of beta thalassemia carriers.
    Mehta BC; Pandya BG
    Am J Hematol; 1987 Feb; 24(2):137-41. PubMed ID: 3812467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum ferritin in evaluation of iron status in children.
    Madanat F; El-Khateeb M; Tarawaneh M; Hijazi S
    Acta Haematol; 1984; 71(2):111-5. PubMed ID: 6421048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron status and oxidative stress in beta-thalassemia patients in Jakarta.
    Laksmitawati DR; Handayani S; Udyaningsih-Freisleben SK; Kurniati V; Adhiyanto C; Hidayat J; Kusnandar S; Dillon HS; Munthe BG; Wirawan R; Soegianto RR; Ramelan W; Freisleben HJ
    Biofactors; 2003; 19(1-2):53-62. PubMed ID: 14757977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.